BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12649142)

  • 1. IVIg-mediated amelioration of murine ITP via FcgammaRIIB is independent of SHIP1, SHP-1, and Btk activity.
    Crow AR; Song S; Freedman J; Helgason CD; Humphries RK; Siminovitch KA; Lazarus AH
    Blood; 2003 Jul; 102(2):558-60. PubMed ID: 12649142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IVIg-mediated amelioration of murine ITP via FcgammaRIIb is not necessarily independent of SHIP-1 and SHP-1 activity.
    van Mirre E; van Royen A; Hack CE
    Blood; 2004 Mar; 103(5):1973; author reply 1974. PubMed ID: 14976068
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcgamma receptors FcgammaRIIB and FcgammaRIIA.
    Huang ZY; Hunter S; Kim MK; Indik ZK; Schreiber AD
    J Leukoc Biol; 2003 Jun; 73(6):823-9. PubMed ID: 12773515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation.
    Nadler MJ; Chen B; Anderson JS; Wortis HH; Neel BG
    J Biol Chem; 1997 Aug; 272(32):20038-43. PubMed ID: 9242674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis reveals multiple distinct sites within Fc gamma receptor IIB that function in inhibitory signaling.
    Fong DC; Brauweiler A; Minskoff SA; Bruhns P; Tamir I; Mellman I; Daeron M; Cambier JC
    J Immunol; 2000 Oct; 165(8):4453-62. PubMed ID: 11035084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
    Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
    J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partially distinct molecular mechanisms mediate inhibitory FcgammaRIIB signaling in resting and activated B cells.
    Brauweiler A; Tamir I; Marschner S; Helgason CD; Cambier JC
    J Immunol; 2001 Jul; 167(1):204-11. PubMed ID: 11418650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells.
    Gast M; Preisinger C; Nimmerjahn F; Huber M
    Front Immunol; 2018; 9():1937. PubMed ID: 30210494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation.
    Isnardi I; Bruhns P; Bismuth G; Fridman WH; Daëron M
    Immunol Lett; 2006 Apr; 104(1-2):156-65. PubMed ID: 16406061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils.
    Kepley CL; Cambier JC; Morel PA; Lujan D; Ortega E; Wilson BS; Oliver JM
    J Allergy Clin Immunol; 2000 Aug; 106(2):337-48. PubMed ID: 10932079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 antibody-mediated amelioration of murine immune thrombocytopenia (ITP): mouse background determines the effect of FcγRIIb genetic disruption.
    Crow AR; Amash A; Lazarus AH
    Transfusion; 2015 Jun; 55(6 Pt 2):1492-500. PubMed ID: 25496771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation.
    Sármay G; Koncz G; Pecht I; Gergely J
    Immunol Lett; 1999 May; 68(1):25-34. PubMed ID: 10397152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by fcgamma RIIB.
    Bruhns P; Vely F; Malbec O; Fridman WH; Vivier E; Daeron M
    J Biol Chem; 2000 Dec; 275(48):37357-64. PubMed ID: 11016922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling.
    Ono M; Okada H; Bolland S; Yanagi S; Kurosaki T; Ravetch JV
    Cell; 1997 Jul; 90(2):293-301. PubMed ID: 9244303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB.
    Ono M; Bolland S; Tempst P; Ravetch JV
    Nature; 1996 Sep; 383(6597):263-6. PubMed ID: 8805703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Src homology 2 domain-containing inositol 5-phosphatase 1 mediates cell cycle arrest by FcgammaRIIB.
    Malbec O; Schmitt C; Bruhns P; Krystal G; Fridman WH; Daëron M
    J Biol Chem; 2001 Aug; 276(32):30381-91. PubMed ID: 11359765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-clustering of Fcgamma and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
    Koncz G; Tóth GK; Bökönyi G; Kéri G; Pecht I; Medgyesi D; Gergely J; Sármay G
    Eur J Biochem; 2001 Jul; 268(14):3898-906. PubMed ID: 11453982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic interactions of Fc gamma receptor IIB with filamin-bound SHIP1 amplify filamentous actin-dependent negative regulation of Fc epsilon receptor I signaling.
    Lesourne R; Fridman WH; Daëron M
    J Immunol; 2005 Feb; 174(3):1365-73. PubMed ID: 15661894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of IL-4- and CD40-induced B-lymphocyte activation by intravenous immunoglobulin is not mediated through the inhibitory IgG receptor FcgammaRIIb.
    Zhuang Q; Bisotto S; Fixman ED; Mazer B
    J Allergy Clin Immunol; 2002 Sep; 110(3):480-3. PubMed ID: 12209098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of mast cell proliferation by FcgammaRIIB.
    Malbec O; Attal JP; Fridman WH; Daëron M
    Mol Immunol; 2002 Sep; 38(16-18):1295-9. PubMed ID: 12217398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.